Back

Amiodarone does not significantly affect the success rate of ventricular fibrillation induction tests performed during or after ICD implantation. Insights from the German DEVICE registry

16 April 2023 (10:40 - 12:00)
Organised by:
Congress Presentation Part of: ePoster session 5 Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Felix Wiedmann

University Hospital Heidelberg, Heidelberg (Germany)

7 More presentations in this session

Presentation thumbnail
Refinement of voltage-based atrial scar assessment using pacing thresholds and local impedance
Doctor A. Bates (Southampton, GB)
Abstract Slides
Presentation thumbnail
Assessment of scar between atria, rhythms and atrial fibrillation types: does ultra high density mapping offer new insights?
Doctor A. Bates (Southampton, GB)
Abstract Slides
Presentation thumbnail
Cardioneuroablation for the treatment of vasovagal syncope, functional sinus node dysfunction and functional atrioventricular block: initial experience in one center
Doctor C. Minguito Carazo (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Defibrillation test in paediatric patients: should be done?
Doctor G. Sarquella Brugada (Barcelona, ES)
Abstract Slides
Presentation thumbnail
The new tactiflex ablation catheter: reducing the time for radiofrequency atrial fibrillation ablation
Doctor L. D Angelo (Ancona, IT)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 5

The Event

Event poster

EHRA 2023

16 April 2023 10:40 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources